Prevalence of exocrine pancreatic insufficiency in type 2 diabetes mellitus with poor glycemic control

Terzin, V [Terzin, Viktória (gasztroenterológia), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Várkonyi, T [Várkonyi, Tamás (Belgyógyászat, di...), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Szabolcs, A [Szabolcs, Annamária (belgyógyászat), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Lengyel, C [Lengyel, Csaba Attila (diabetológia, bel...), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Takács, T [Takács, Tamás (Orvostudomány), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Zsóri, G [Zsóri, Gábor (Orvos), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Stájer, A [Stájer, Anette (fogászat, mikrobi...), author] Department of Prosthodontics (SZTE); Palkó, A [Palkó, András (Radiológia), author] Department of Radiology (SZTE / ASZMS); Wittmann, T [Wittmann, Tibor (Emésztőszervek be...), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine); Pálinkás, A [Pálinkás, Attila (orvostudomány, ka...), author]; Czakó, L ✉ [Czakó, László (gasztroenterológia), author] First Department of Internal Medicine (SZTE / ASZMS / DIMedicine)

English Article (Journal Article) Scientific
Published: PANCREATOLOGY 1424-3903 1424-3911 14 (5) pp. 356-360 2014
  • SJR Scopus - Endocrinology: Q2
Subjects:
  • Biological sciences
  • Clinical medicine
  • MEDICAL AND HEALTH SCIENCES
  • Radiology, nuclear medicine and medical imaging
Objectives: To evaluate the relationship between exocrine pancreatic insufficiency and the level of glycemic control in diabetes (DM). Methods: Patients with type 2 DM treated in our clinic were prospectively recruited into the study. Pancreatic diabetes was excluded. Cases with HbA1c ≥7% formed Group A ( n=59), and with HbA1c <7% Group B ( n=42). The fecal level of pancreatic elastase (PE-1) was measured and morphological examinations of the pancreas were performed. Results: The PE-1 level was significantly lower in Group A than in Group B (385.9±171.1μg/g, vs. 454.6±147.3μg/g, p=0.038). The PE-1 level was not correlated with HbA1c ( r=-0.132, p=0.187), the duration of DM ( r=-0.046, p=0.65), age ( r=0.010, p=0.921), BMI ( r=0.203, p=0.059), or pancreatic steatosis ( r=0.117, p=0.244). The size of the pancreas did not differ significantly between Groups A andB. Conclusions: An exocrine pancreatic insufficiency demonstrated by fecal PE-1 determination is more frequent in type 2 DM patients with poor glycemic control. The impaired exocrine pancreatic function cannot be explained by an alteration in the size of the pancreas or by pancreatic steatosis. © 2014 IAP and EPC.
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2026-02-14 00:28